CLOPRA-"YELLOW"

Post-LOE

metoclopramide hydrochloride

Quantum Genomics

ANDAORALTABLET

Approved

Oct 1985

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CLOPRA-"YELLOW" (metoclopramide hydrochloride) by Quantum Genomics is gastric, biliary, or pancreatic secretions. Approved for vomiting associated with emetogenic cancer chemotherapy, postoperative nausea, vomiting in those circumstances where nasogastric suction is undesirable. First approved in 1985.

Drug data last refreshed 20h ago

Mechanism of Action

gastric, biliary, or pancreatic secretions. The exact mechanism of action of metoclopramide in the treatment of gastroesophageal reflux and acute and recurrent diabetic gastroparesis has not been fully established. It seems to sensitize tissues to the action of acetylcholine. The effect of…

Indications (3)

vomiting associated with emetogenic cancer chemotherapy

Worked on CLOPRA-"YELLOW" at Quantum Genomics? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.